Trystan Macdonald
Target Product Profile for a Machine Learning–Automated Retinal Imaging Analysis Software for Use in English Diabetic Eye Screening: Protocol for a Mixed Methods Study
Macdonald, Trystan; Dinnes, Jacqueline; Maniatopoulos, Gregory; Taylor-Phillips, Sian; Shinkins, Bethany; Hogg, Jeffry; Dunbar, John Kevin; Solebo, Ameenat Lola; Sutton, Hannah; Attwood, John; Pogose, Michael; Given-Wilson, Rosalind; Greaves, Felix; Macrae, Carl; Pearson, Russell; Bamford, Daniel; Tufail, Adnan; Liu, Xiaoxuan; Denniston, Alastair K
Authors
Jacqueline Dinnes
Gregory Maniatopoulos
Sian Taylor-Phillips
Bethany Shinkins
Jeffry Hogg
John Kevin Dunbar
Ameenat Lola Solebo
Hannah Sutton
John Attwood
Michael Pogose
Rosalind Given-Wilson
Felix Greaves
Professor CARL MACRAE CARL.MACRAE@NOTTINGHAM.AC.UK
PROFESSOR OF ORGANISATIONAL BEHAVIOUR AND PSYCHOLOGY
Russell Pearson
Daniel Bamford
Adnan Tufail
Xiaoxuan Liu
Alastair K Denniston
Abstract
Background: Diabetic eye screening (DES) represents a significant opportunity for the application of machine learning (ML) technologies, which may improve clinical and service outcomes. However, successful integration of ML into DES requires careful product development, evaluation, and implementation. Target product profiles (TPPs) summarize the requirements necessary for successful implementation so these can guide product development and evaluation. Objective: This study aims to produce a TPP for an ML-automated retinal imaging analysis software (ML-ARIAS) system for use in DES in England. Methods: This work will consist of 3 phases. Phase 1 will establish the characteristics to be addressed in the TPP. A list of candidate characteristics will be generated from the following sources: an overview of systematic reviews of diagnostic test TPPs; a systematic review of digital health TPPs; and the National Institute for Health and Care Excellence’s Evidence Standards Framework for Digital Health Technologies. The list of characteristics will be refined and validated by a study advisory group (SAG) made up of representatives from key stakeholders in DES. This includes people with diabetes; health care professionals; health care managers and leaders; and regulators and policy makers. In phase 2, specifications for these characteristics will be drafted following a series of semistructured interviews with participants from these stakeholder groups. Data collected from these interviews will be analyzed using the shortlist of characteristics as a framework, after which specifications will be drafted to create a draft TPP. Following approval by the SAG, in phase 3, the draft will enter an internet-based Delphi consensus study with participants sought from the groups previously identified, as well as ML-ARIAS developers, to ensure feasibility. Participants will be invited to score characteristic and specification pairs on a scale from “definitely exclude” to “definitely include,” and suggest edits. The document will be iterated between rounds based on participants’ feedback. Feedback on the draft document will be sought from a group of ML-ARIAS developers before its final contents are agreed upon in an in-person consensus meeting. At this meeting, representatives from the stakeholder groups previously identified (minus ML-ARIAS developers, to avoid bias) will be presented with the Delphi results and feedback of the user group and asked to agree on the final contents by vote. Results: Phase 1 was completed in November 2023. Phase 2 is underway and expected to finish in March 2024. Phase 3 is expected to be complete in July 2024. Conclusions: The multistakeholder development of a TPP for an ML-ARIAS for use in DES in England will help developers produce tools that serve the needs of patients, health care providers, and their staff. The TPP development process will also provide methods and a template to produce similar documents in other disease areas.
Citation
Macdonald, T., Dinnes, J., Maniatopoulos, G., Taylor-Phillips, S., Shinkins, B., Hogg, J., Dunbar, J. K., Solebo, A. L., Sutton, H., Attwood, J., Pogose, M., Given-Wilson, R., Greaves, F., Macrae, C., Pearson, R., Bamford, D., Tufail, A., Liu, X., & Denniston, A. K. (2024). Target Product Profile for a Machine Learning–Automated Retinal Imaging Analysis Software for Use in English Diabetic Eye Screening: Protocol for a Mixed Methods Study. JMIR Research Protocols, 13(1), Article e50568. https://doi.org/10.2196/50568
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 13, 2024 |
Online Publication Date | Mar 27, 2024 |
Publication Date | 2024 |
Deposit Date | Apr 11, 2024 |
Publicly Available Date | Apr 16, 2024 |
Journal | JMIR Research Protocols |
Electronic ISSN | 1929-0748 |
Publisher | JMIR Publications |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 1 |
Article Number | e50568 |
DOI | https://doi.org/10.2196/50568 |
Keywords | Artificial intelligence ; design ; developers ; diabetes mellitus ; diabetic eye screening ; diabetic retinopathy ; diabetic ; DM ; England ; eye screening ; imaging analysis software ; implementation ; machine learning ; retinal imaging ; study protocol |
Public URL | https://nottingham-repository.worktribe.com/output/33563369 |
Publisher URL | https://www.researchprotocols.org/2024/1/e50568 |
Files
PDF
(267 Kb)
PDF
You might also like
Editorial: Organizational risk and the COVID-19 pandemic
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search